Trial Profile
A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence Following Radical Prostatectomy.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Satraplatin (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- Sponsors GPC Biotech Inc
- 05 Feb 2008 Status changed from recruiting to discontinued. Updated from ClinicalTrials.gov.
- 10 Sep 2007 Status changed from initiated to recruiting.
- 30 Jul 2007 New trial record.